AMNIOTIC FLUID

Yves Laure Pimentel · 70問 · 2年前

通報

問題一覧

Present in Amnion

AMNIOTIC FLUID

(membranous sac that surrounds the fetus)

Amnion

Functions: o Provide a protective cushion for the fetus, allow fetal movement o Stabilize the temp & protect fetus from temperature changes o Permit lung development

AMNIOTIC FLUID

Needle aspiration of amniotic fluid into the amniotic sac (fransabdominal amniocentesis)

AMNIOCENTESIS

volume collected (1st-3 ml is discarded: blood, fissue fluid contamination)

30 ml

Safely done after amniocentesis safely done after?

14 weeks of gestation

weeks Chromosome analysis, genetic defects

16th weeks

intrauterine growth restriction

near the end of 2nd trimester

Fetal Are. fetal ng maturity, fetal haemolytic dse

3rd trimester

protected from light

fluid for HDN:

Fluid for Fetal Lung Maturity: storage

placed on ICE OR REFRIGERATE

CENTRIFUGATION to Prevent phospholipid loss

Low speed centrifuge (500-1000g for <5min):

Cytogenetic/ Microbiology: storage

room temperature or body temperature

Chemical Testing:

separate cellular elements and debris as soon as possible

Regulated by the balance bet. fetal urine, lung fluid, absorption from fetal swallowing and intramembranous flow (Absorption of amniotic fluid water & solutes into the fetal vascular system)

VOLUME

Peak: VOLUME & gradually decreases

800-1200 ML

> 1200 mL

POLYHYDRATION

<800 ml

OLIGOHYDRATION

1ST trimester: ML derived from maternal circulation

35 ml

after 1ST trimester: Is the major contributor to the amniotic fluig volume

FETAL URINE

If not swallowed: (fetal distress, neural tube disorders)

POLYHYDRAMNIOS

INCREASED Swallowing: [congenital malformations, rupture of amniotic membrane,decelerated heart rate - fetal death

OLIGOHYDRAMNIOS

Fetus secretes lung liquid in AF

3rd half of pregnancy

ultimate source of AF H20 & solutes

Placenta

Neural tube defects: CSF in AF (Markers:

ALPHA FETO PROTEIN, ACETYLCHOLINESTERASE

AF creatinine: Fetal Age

Bet. 1.5-2 mg/dl: 36 weeks gestation >2mg/dl: > 36 weeks

Amniotic Fluid CREATININE

<3.5 MG/DL

Maternal Urine CREATININE

10 MG/DL

Maternal Urine UREA

300 MG/DL

Amniotic Fluid UREA

30 MG/DL

Fern-like Crystals due to CHON, NaCl (+)

Amniotic Fluid

Cause: Premature Membrane Rupture

Amniotic Fluid

Puncture of the bladder in amniocentesis

Maternal Urine

APPEARANCE Normal COLOR AND CLARITY

COLORLESS AND SLIGHTLY TURBID

HDN (bilirubin)

yellow

HDN (bilirubin)

Meconium (Fetus' 1ST bowel movement)

DARK GREEN

Meconium (Fetus' 1ST bowel movement)

Fetal Death

DARK RED BROWN

FETAL DEATH

is measured by Spectrophotometer using serial dilutions

AF bilirubin

Normal fluid:

OPTICAL DENSITY AT 365 NM DECREASES TO 550 NM

(+) Bilirubin: (Maximum bilirubin absorption) OPTICAL DENSITY

OPTICAL DENSITY 450 NM

A 450 is then plotted to ? to measure the severity of the HDN

LILY GRAPH

Zone 1: No more than a mildly affected fetus =

observe fetus

Zone 2: Moderate hemolysis:

Close monitoring, treatment

Zone 3: Severe hemolysis=

Labor/ Intra-uterine Exchange transfusion

NEURAL TUBE DEFECTS Detected by Maternal serum ? (INCREASED Anencephaly, Spina bifida, multiple pregnancy)

ALPHA FETO PROTEIN

Major protein produced by the fetus liver at early gestation prior to 18" weeks

ALPHA FETO PROTEIN

Major protein produced by the fetus liver at early gestation prior to HOW MANY WEEKS?

18TH weeks

Normal: fetus produces maximal AFP bet ? weeks

12 & 15 weeks

NEURAL TUBE DEFECTS Reported:

MOM- MULTIPLES OF THE MEDIAN

Abnormal

GREATER THAN 2

more specific for detecting neural tube defects

AF Acetylcholinesterase

Most frequent complication of early delivery caused by insufficient lung surfactant and lung immaturity

RESPIRATORY DISTRESS SYNDROME (RDS)

Surfactant allows the alveoli to remain open and keeps them from collapsing by the decreasing the surface tension and allows them w/ air more easily

RESPIRATORY DISTRESS SYNDROME (RDS)

Primary component of surfactant & make the alveolar lining account for alveolar stability

LECITHIN

Produced at low at constant rate until 35TH week

LECITHIN

LECITHIN Produced at low at constant rate until ?

35TH week

Lipid that is produced at constant rate after about 26 weeks of gestation

SPHINGOMYELIN

SPHINGOMYELIN Lipid that is produced at constant rate after about ?

26 weeks of gestation

Serve asa control on w/c to base the rise in lecithin

SPHINGOMYELIN

Prior to 35" week: ? (small amount of lecithin are only produced)

<1.6

Lecithin increases while sphingomyelin at constant rate

After 35™ week:

L/S ratio: will rise to

2 or higher

L/S ratio of 2:

prevent alveolar collapse

: prevent alveolar collapse

L/S ratio of 2

QUANTITATIVE MEASUREMENT OF LECITHIN AND SPHIGOMYELIN

THIN LAYER CHROMATOGRAPHY

Also essential for lung maturity and can detected after 35 weeks

Phosphatidyl Glycerol

Phosphatidyl Glycerol Delayed production:

MATERNAL DIABETES

Uses polyclonal anti-PG antibodies

Agglutination Test (Aminostat FLM)

Agglutination Test (Aminostat FLM) Negative/ No agglutination:

Pulmonary immaturity

Agglutination Test (Aminostat FLM) Positive:

Pulmonary maturity

shaken for 15sec > stand for 15 min

amniotic fluid + 95% ethanol

amniotic fluid + 95% ethanol shaken for 15sec > stand for 15 min

Foam Stability Index/ Foam Shake Test

Semi-quantitative measure of FLM: Foam Stability Index/ Foam Shake Test

>/= 47 FLM

Storage form of pyimopary surfactant

LAMELLAR BODIES

LAMELLAR BODIES Secreted by ?and absorbed into alveolar spaces to provide surfactant

TYPE II PNEUMOCYTES

Secreted by TYPE II PNEUMOCYTES and absorbed into alveolar spaces to provide surfactant

LAMELLAR BODIES

Enter AF at 26 weeks and 1 conc:

50,000- 200, 000/ul of 3 trimester

(+): Increases the OD of the amniotic fluid at

650 nm

Same diameter as platelets

Lamellar Body Count

LBC: FLM NORMAL

>50,000/ul = FLM

LBC: Immature

<15,000/ul

Measure Surfactant to Albumin (S/A) ratio to measure FLM

Microviscosity: Fluorescence Polarization Assay

Principle: Phospholipid decreases microviscosity of AF

Microviscosity: Fluorescence Polarization Assay

Fluorescent dye bound to surfactant:

LONGER FLUORESENCE AND LOWER POLARIZATION

Fluorescent dye bound to albumin:

DECREASE FLUORESCENCE AND HIGHER POLARIZATION

USED AS INTERVAL STANDARD

albumin

S/A ratio: FLM

55 MG/G

S/A ratio: indeterminate

40-54 MG/G

S/A ratio: Immature Lung

<39 MG/G

other names parasitology

other names parasitology

70問 • 2年前

Yves Laure Pimentel · 111問 · 2年前

PARASITOLOGY

PARASITOLOGY

111問 • 2年前

Yves Laure Pimentel · 64問 · 2年前

HTMLBE

HTMLBE

64問 • 2年前

Yves Laure Pimentel · 61問 · 2年前

CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

61問 • 2年前

Yves Laure Pimentel · 69問 · 2年前

HISTOPATHOLOGY

HISTOPATHOLOGY

69問 • 2年前

CC-2 SPECTROPHOTOMETRY

CC-2 SPECTROPHOTOMETRY

Yves Laure Pimentel · 41問 · 2年前

CC-3 ELECTROPHORESIS

CC-3 ELECTROPHORESIS

41問 • 2年前

Yves Laure Pimentel · 87問 · 2年前

AUBF LAB SAFETY

AUBF LAB SAFETY

87問 • 2年前

CSF 1

CSF 1

Yves Laure Pimentel · 82問 · 2年前

CSF 2

CSF 2

82問 • 2年前

SEMEN 1

SEMEN 1

Yves Laure Pimentel · 7問 · 2年前

SEMEN 2

SEMEN 2

7問 • 2年前

SYNOVIAL FLUID 1

SYNOVIAL FLUID 1

Yves Laure Pimentel · 6問 · 2年前

SYNOVIAL FLUID 2

SYNOVIAL FLUID 2

6問 • 2年前

Yves Laure Pimentel · 25問 · 2年前

SEROUS FLUID

SEROUS FLUID

25問 • 2年前

Yves Laure Pimentel · 44問 · 2年前

PLEURAL FLUID

PLEURAL FLUID

44問 • 2年前

Yves Laure Pimentel · 18問 · 2年前

PERICARDIAL FLUID

PERICARDIAL FLUID

18問 • 2年前

Yves Laure Pimentel · 30問 · 2年前

PERITONEAL FLUID/ ASCITIC FLUID

PERITONEAL FLUID/ ASCITIC FLUID

30問 • 2年前

Yves Laure Pimentel · 80問 · 2年前

FECALYSIS

FECALYSIS

80問 • 2年前

Yves Laure Pimentel · 89問 · 2年前

OTHER BODY FLUIDS

OTHER BODY FLUIDS

89問 • 2年前

Yves Laure Pimentel · 86問 · 2年前

MTLBE- SUHO NOTES

MTLBE- SUHO NOTES

86問 • 2年前

Yves Laure Pimentel · 35問 · 2年前

MTLBE..

MTLBE..

35問 • 2年前

Yves Laure Pimentel · 19問 · 1年前

CC- CHROMATOGRAPHY

CC- CHROMATOGRAPHY

19問 • 1年前

Yves Laure Pimentel · 14問 · 1年前

CC-OSMOMETRY

CC-OSMOMETRY

14問 • 1年前

Yves Laure Pimentel · 43問 · 1年前

CC-ELECTROCHEMISTRY TECHNIQUES

CC-ELECTROCHEMISTRY TECHNIQUES

43問 • 1年前

Yves Laure Pimentel · 49問 · 2年前

CC- CARBOHYDRATES

CC- CARBOHYDRATES

49問 • 2年前

Yves Laure Pimentel · 97問 · 2年前

CC- DIABETES MELLITUS

CC- DIABETES MELLITUS

97問 • 2年前

Yves Laure Pimentel · 57問 · 2年前

MAJOR LIPOPROTEINS

MAJOR LIPOPROTEINS

57問 • 2年前

Yves Laure Pimentel · 63問 · 2年前

MINOR LIPOPROTEINS

MINOR LIPOPROTEINS

63問 • 2年前

Yves Laure Pimentel · 37問 · 2年前

PROTEINS

PROTEINS

37問 • 2年前

Yves Laure Pimentel · 91問 · 2年前

PLASMA PROTEINS 1

PLASMA PROTEINS 1

91問 • 2年前

Yves Laure Pimentel · 98問 · 2年前

PLASMA PROTEINS 2 (ALPHA 2 REGION)

PLASMA PROTEINS 2 (ALPHA 2 REGION)

98問 • 2年前

Yves Laure Pimentel · 61問 · 2年前

MISCELLANEOUS PROTEINS

MISCELLANEOUS PROTEINS

61問 • 2年前

Liver Function Test 1

Liver Function Test 1

Yves Laure Pimentel · 96問 · 2年前

Liver Function Test 2

Liver Function Test 2

96問 • 2年前

Yves Laure Pimentel · 33問 · 2年前

TUMOR MARKERS

TUMOR MARKERS

33問 • 2年前

Yves Laure Pimentel · 41問 · 2年前

KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

41問 • 2年前

Yves Laure Pimentel · 17問 · 2年前

GLYCOGEN STORAGE DISEASES

GLYCOGEN STORAGE DISEASES

17問 • 2年前

Yves Laure Pimentel · 14問 · 2年前

LIPID STORAGE DISEASES

LIPID STORAGE DISEASES

14問 • 2年前

Yves Laure Pimentel · 71問 · 2年前

PROTEINS

PROTEINS

71問 • 2年前

Yves Laure Pimentel · 7問 · 2年前

QUICK FIRE- ELECTRODES

QUICK FIRE- ELECTRODES

7問 • 2年前

Yves Laure Pimentel · 10問 · 2年前

ELECTROLYTES

ELECTROLYTES

10問 • 2年前

Yves Laure Pimentel · 27問 · 2年前

DRUGS

DRUGS

27問 • 2年前

Yves Laure Pimentel · 12問 · 2年前

TOXIC AGENTS:

TOXIC AGENTS:

12問 • 2年前

HEMATOLOGY 1 (HEMATOPOIESIS 1)

HEMATOLOGY 1 (HEMATOPOIESIS 1)

Yves Laure Pimentel · 29問 · 2年前

HEMATOLOGY (HEMATOPOIESIS 2)

HEMATOLOGY (HEMATOPOIESIS 2)

29問 • 2年前

Yves Laure Pimentel · 25問 · 2年前

hema diseases

hema diseases

25問 • 2年前

Yves Laure Pimentel · 43問 · 2年前

AML

AML

43問 • 2年前

Yves Laure Pimentel · 71問 · 2年前

GLOBIN SYNTHESIS

GLOBIN SYNTHESIS

71問 • 2年前

Yves Laure Pimentel · 31問 · 2年前

HEMATOLOGY REFERENCE RANGES

HEMATOLOGY REFERENCE RANGES

31問 • 2年前

Yves Laure Pimentel · 34問 · 2年前

DISORDERS OF PRIMARY HEMOSTASIS

DISORDERS OF PRIMARY HEMOSTASIS

34問 • 2年前

Yves Laure Pimentel · 37問 · 2年前

PLATELET DISORDERS

PLATELET DISORDERS

37問 • 2年前

CHARACTERISTICS OF CLOTTING FACTORS

CHARACTERISTICS OF CLOTTING FACTORS

Yves Laure Pimentel · 12問 · 2年前

4. CLASSIFICATION OF MACROPHAGE

4. CLASSIFICATION OF MACROPHAGE

12問 • 2年前

Yves Laure Pimentel · 39問 · 2年前

3. NATURAL OR INNATE IMMUNITY

3. NATURAL OR INNATE IMMUNITY

39問 • 2年前

Yves Laure Pimentel · 55問 · 2年前

5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

55問 • 2年前

Yves Laure Pimentel · 37問 · 2年前

6. PHAGOCYTOSIS Chemotaxis

6. PHAGOCYTOSIS Chemotaxis

37問 • 2年前

Yves Laure Pimentel · 44問 · 2年前

8. NATURE OF ANTIGEN

8. NATURE OF ANTIGEN

44問 • 2年前

Yves Laure Pimentel · 50問 · 2年前

9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

50問 • 2年前

Yves Laure Pimentel · 69問 · 2年前

1. HISTORY

1. HISTORY

69問 • 2年前

Yves Laure Pimentel · 38問 · 2年前

2. TYPES OF IMMUNITY

2. TYPES OF IMMUNITY

38問 • 2年前

Yves Laure Pimentel · 21問 · 2年前

7. PHAGOCYTOSIS Engulfment and Digestion

7. PHAGOCYTOSIS Engulfment and Digestion

21問 • 2年前

Yves Laure Pimentel · 15問 · 2年前

8. PHAGOCYTOSIS EXOCYTOSIS

8. PHAGOCYTOSIS EXOCYTOSIS

15問 • 2年前

Yves Laure Pimentel · 32問 · 2年前

10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

32問 • 2年前

Yves Laure Pimentel · 30問 · 2年前

11. TRANSPLANTATION IMMUNOLOGY

11. TRANSPLANTATION IMMUNOLOGY

30問 • 2年前

Yves Laure Pimentel · 38問 · 2年前

2. LYMPHOID ORGANS

2. LYMPHOID ORGANS

38問 • 2年前

Yves Laure Pimentel · 48問 · 2年前

3. CLUSTER OF DIFFERENTIATION

3. CLUSTER OF DIFFERENTIATION

48問 • 2年前

Yves Laure Pimentel · 35問 · 2年前

4. T-CELL DIFFERENTIATION

4. T-CELL DIFFERENTIATION

35問 • 2年前

Yves Laure Pimentel · 18問 · 2年前

5. T CELL IMMUNODEFICIENCIES

5. T CELL IMMUNODEFICIENCIES

18問 • 2年前

Yves Laure Pimentel · 44問 · 2年前

6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

44問 • 2年前

Yves Laure Pimentel · 23問 · 2年前

7. B CELL IMMUNODEFICIENCIES

7. B CELL IMMUNODEFICIENCIES

23問 • 2年前

Yves Laure Pimentel · 34問 · 2年前

8. COMBINED T CELL AND B CELL DEFICIENCIES

8. COMBINED T CELL AND B CELL DEFICIENCIES

34問 • 2年前

Yves Laure Pimentel · 12問 · 2年前

9. COMPARISON OF T AND B CELLS

9. COMPARISON OF T AND B CELLS

12問 • 2年前

Yves Laure Pimentel · 16問 · 2年前

10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

16問 • 2年前

Yves Laure Pimentel · 15問 · 2年前

11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

15問 • 2年前

Yves Laure Pimentel · 79問 · 2年前

12. ANTIBODY

12. ANTIBODY

79問 • 2年前

Yves Laure Pimentel · 97問 · 2年前

13. TYPES OF ANTIBODIES

13. TYPES OF ANTIBODIES

97問 • 2年前

Yves Laure Pimentel · 11問 · 2年前

14. MONOCLONAL ANTIBODIES

14. MONOCLONAL ANTIBODIES

11問 • 2年前

Yves Laure Pimentel · 23問 · 2年前

1. INTERLEUKINS

1. INTERLEUKINS

23問 • 2年前

Yves Laure Pimentel · 28問 · 2年前

2. INTERFERONS

2. INTERFERONS

28問 • 2年前

Yves Laure Pimentel · 8問 · 2年前

3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

8問 • 2年前

Yves Laure Pimentel · 19問 · 2年前

4. COMPLEMENT SYSTEM

4. COMPLEMENT SYSTEM

19問 • 2年前

Yves Laure Pimentel · 76問 · 2年前

15. COMPLEMENT SYSTEM

15. COMPLEMENT SYSTEM

76問 • 2年前

Yves Laure Pimentel · 21問 · 2年前

16. SYSTEM CONTROLS/COMPLEMENT REGULATION

16. SYSTEM CONTROLS/COMPLEMENT REGULATION

21問 • 2年前

Yves Laure Pimentel · 29問 · 2年前

17. COMPLEMENT AND DISEASE STATES

17. COMPLEMENT AND DISEASE STATES

29問 • 2年前

Yves Laure Pimentel · 19問 · 2年前

18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

19問 • 2年前

Yves Laure Pimentel · 22問 · 2年前

19. CYTOKINES

19. CYTOKINES

22問 • 2年前

Yves Laure Pimentel · 24問 · 2年前

20. INTERLEUKINS

20. INTERLEUKINS

24問 • 2年前

Yves Laure Pimentel · 21問 · 2年前

21. INTERFERONS, TNF, TGF, CHEMOKINE

21. INTERFERONS, TNF, TGF, CHEMOKINE

21問 • 2年前

Yves Laure Pimentel · 54問 · 2年前

1. SERO

1. SERO

54問 • 2年前

Yves Laure Pimentel · 38問 · 2年前

2. PRECIPITATION

2. PRECIPITATION

38問 • 2年前

Yves Laure Pimentel · 17問 · 2年前

3. PASSIVE IMMUNODIFFUSION

3. PASSIVE IMMUNODIFFUSION

17問 • 2年前

Yves Laure Pimentel · 15問 · 2年前

4. OUCHTERLONY

4. OUCHTERLONY

15問 • 2年前

Yves Laure Pimentel · 9問 · 2年前

5. ELECTROPHORETIC TECHNIQUE

5. ELECTROPHORETIC TECHNIQUE

9問 • 2年前

Yves Laure Pimentel · 11問 · 2年前

6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

11問 • 2年前

Yves Laure Pimentel · 29問 · 2年前

7. IMMUNOFIXATION ELECTROPHORESIS

7. IMMUNOFIXATION ELECTROPHORESIS

29問 • 2年前